Title card for Bile Is a Hormone, Not Soap showing Dr. Padda beside the chapter title text

September 12, 2026

Diarrhea after gallbladder removal

Diarrhea After Cholecystectomy: The Test Almost Nobody Orders

by - Dr. Gurpreet Singh Padda, MD, MBA, MHP

Diarrhea after cholecystectomy is usually bile acid diarrhea. Without a gallbladder, bile trickles into the bowel instead of arriving in pulses. The colon answers the extra bile with water. It has a name, a test and a treatment. Yet of 9,439 people who had the operation, only 2.1% were ever tested for it.

She is fifty-seven, and her gallbladder came out eleven years ago. The pain it was blamed for did settle. What began about four months later has not. Urgent, loose, pale stools after anything fatty, most days of the week, for a decade. Diarrhea after cholecystectomy is the name for that. In eleven years nobody tested her for it.

Instead she got two colonoscopies, a celiac screen, and a label of irritable bowel syndrome. The chapter video, Bile Is a Hormone, Not Soap, walks through the body’s workings. What follows is what a pain practice does with it. This is a mechanical result of an operation, not a personality trait of the bowel.

The operation was reasonable. The follow-up was not.

Start with the audit, because the numbers are the scandal. Of 9,439 people who had a gallbladder removed, 202, or 2.1%, were ever tested for diarrhea afterward. Among those tested, 62.8% had bile acid diarrhea. Published rates for the symptom run anywhere from 2.1% to 57.2%, depending on the study. That tells you how little anyone has bothered to count.

Read that honestly. The audit does not say most people who lose a gallbladder get this. Only patients a doctor already suspected were sent for the scan. So the positive rate describes the suspicion, not the whole population. And nobody who kept a gallbladder was compared. What it does show is this. A condition with a name, a test and a treatment goes unexamined in the vast majority of patients who had the operation.

Why is no mystery. It comes down to categories. Removing the organ is billed, scheduled and followed up. The result gets a syndrome name instead. And irritable bowel syndrome is where testing goes to stop. Anyone who has lived under a diagnosis of exclusion knows the shape of this. A bowel blamed on stress stops being checked for anything else.

Diarrhea after cholecystectomy: why a colon answers bile with water

A gallbladder stores bile between meals. It fires it as a burst when fat reaches the small intestine. Without one, bile trickles into a small intestine built to receive it in pulses. More of it travels downstream. The colon reads bile acids as an order to release water. That is the diarrhea. It is a delivery problem.

The amount changes too. The gallbladder lining carries the code for fibroblast growth factor 19 at about 250 times the level of the lower small intestine. So removing it removes the richest source of the hormone that tells the liver when to stop making bile. Bile acid production then at least doubles, and the noon peak of the daily rhythm flattens. Everyone in that study had gallstone disease. So the tissue measured was already abnormal before it came out. And the authors call the step from doubled production to any symptom a possible link, not a proven one.

Here is the correction that changes how I explain this at the bedside. One team tested the tidy version directly. They measured the gallbladder hormone before and after surgery. They found no link at all with bowel habit or stool texture. The hormone-shortage story failed its own test. The delivery story did not. So the line is: more bile, badly timed, into a bowel built for a pulse. Getting that right matters. It is like when a liver problem hides behind normal labs. The mechanism, not the label, decides the next test.

What gets filed as irritable bowel, counted forward

Most of what is known about symptoms after this operation is remembered, not measured. One group did it forward. They gave surveys before a planned keyhole gallbladder removal and again at twelve months. They compared matched people coming through a health check. New functional diarrhea (diarrhea with no visible structural cause) ran 6.6% against 0.2%. New indigestion ran 14.8% against 6.9%. New chronic belly pain ran 11.9% against 4.4%.

The most useful line in that paper is about which symptoms had a mental-health predictor. A tendency to feel stress as body symptoms predicted the new indigestion and the new pain. It did not predict the new diarrhea. Take the direction, not the decimal. This is one year of survey data, and the comparison group differs from surgery patients in more than the operation. Still, a symptom that survives every attempt to explain it as mental has plumbing behind it. That is the same argument as a scan that does not match the pain.

The upper gut fills in when the pulse is gone

Bile is also the main germ-killing rinse for the upper gut. The key is the receptor it acts on, not its soap-like action. The human evidence came by accident. In 27 patients with blocked bile ducts, bile was not reaching the gut. The gut wall got leakier, and antibodies to bacterial toxin rose in their blood. Leakiness moved back toward normal once a surgeon drained the bile into the bowel.

After gallbladder removal, bacterial overgrowth on a breath test ran at 46.8%. It was 26.2% in other gut disorders and 13.3% in healthy people. In that study, the surgery was the only factor that predicted it on its own. In a larger study of gallstone disease, it was the stone-filled gallbladder, not the surgery, that predicted overgrowth. The two results agree once you ask about timing. A stone that blocks the reservoir and a missing reservoir both stop bile from arriving as a burst.

The other side deserves its due. When grown properly in the lab, overgrowth showed up in 4% of irritable bowel patients and 4% of healthy people. And the small rise in counts did not match symptoms. Fair. But a culture is a census. It counts organisms that grow on a lab plate. It never reports what the population is doing with your lunch. And what they do is what makes gas, urgency and pain. What the flora do to appetite is the next piece of the same argument.

Bile is a hormone, which is why this reaches your metabolism

Put a main bile acid on tissue from the human small intestine, and the gene for that growth factor switches on 350-fold. The same molecule hits a second receptor on gut hormone cells. That releases glucagon-like peptide-1 and insulin. Here is the cleanest proof that this is signaling, not digestion. A resin binds bile acids inside the bowel. It is never absorbed and never reaches the pancreas. Across 17 trials and 2,950 patients, it lowered HbA1c by 0.55%. That held up in the trials at low risk of bias.

A molecule you cannot absorb, acting on a receptor in your bowel, moves your blood sugar. That is why a gallbladder argument belongs in a pain practice at all. The same problem that gives a patient ten years of urgency sits on the wiring that sets insulin, appetite and inflammation. That is what makes high insulin a pain problem. Pooled data on a blood marker is a stand-in for real outcomes, and I say so when I prescribe.

What we do with a patient like her

My answer to her started with this: the surgery was defensible. Arguing about it eleven years later helps nobody. For a real bile problem — a stone in the duct, an inflamed gallbladder, classic pain that comes back on demand — removing the organ works, and works well. The failure lies with the unusual patient sent across that bridge, and with the decade of silence after. Treating symptoms after gallbladder surgery comes after the diagnosis is right.

Then we tested instead of assuming. That is the test she should have had a decade ago. Among people with the worst bile acid loss, 96% responded to a bile acid binder. The figure was 80% at the moderate cutoff and 70% at the mild one. In irritable bowel syndrome with diarrhea, 32% of patients pass that moderate cutoff. One warning before you ask: the specific scan is not licensed in the United States. So here the honest route is a supervised trial of treatment, with a set goal and a stop date. You decide it with the doctor who prescribes it. Nothing on this page is a reason to start or stop a medication on your own.

There is a behavior half, and it has a body-based reason. For decades, anyone with a touchy gallbladder was told to keep fat low and the organ quiet. But a quiet gallbladder is a full one. Fat in the small intestine is the signal that empties it. And bile that sits gets concentrated. The advice prescribed the standstill, and surgery collected it. For a patient who still has the organ, that changes what a meal plan is for.

Our position is humbler than a scalpel and humbler than a receptor drug. Restore the flow. Let bile be made, stored and released in a burst when food arrives. Then it can do the two jobs it evolved for. Every study and every number here is laid out in the Chapter 23 Deep Dive, with what each finding proves and where it falls short. Doing nothing costs another decade under a label.

Frequently asked questions

How long after gallbladder surgery can diarrhea start?

It is not always right away. In the case that opens this page, the stools changed about four months after the operation. That is long enough for most people to stop linking the two. Counted forward over twelve months, new functional diarrhea (diarrhea with no visible structural cause) showed up in 6.6% of patients, against 0.2% of the comparison group. The order of events is the most useful thing you can bring to an appointment. An exposure history works the same way.

Is diarrhea after gallbladder removal just irritable bowel syndrome?

That label is where most of these patients land, and it is where testing stops. Bile acid diarrhea has a mechanism, a test and a treatment. And 62.8% of the few post-surgery patients who were tested turned out to have it. Ask directly whether your bile acid handling has been tested, not assumed. A diagnosis of exclusion is not the end of the workup.

Does losing a gallbladder cause bacterial overgrowth?

Bacterial overgrowth on a breath test ran at 46.8% after the operation, against 13.3% in healthy people. In that study, the surgery was the only factor that predicted it on its own. A stone-filled gallbladder predicted it too. So the common factor is bile that never arrives as a burst. Keep in mind that a positive breath test reports fermentation, not a verdict about your symptoms. Repeat antibiotics are rarely the answer to a flora problem.

Can this affect blood sugar and weight?

The bile acid pathway works through hormones, so yes, in principle. A resin that binds bile acids in the bowel and is never absorbed lowered HbA1c by 0.55%. That was across 17 trials and 2,950 patients with type 2 diabetes. That is a blood marker, not a hard outcome. And it is not a weight loss claim. But it does mean the terrain deserves attention alongside the stools. Food and behavior are treatment here, not aftercare.

Ten years is long enough for a label

Did your stools change after a belly operation, and did the workup stop at a syndrome name? Then the mechanism is worth testing, not assuming. Bring the date of the surgery and the date your symptoms started.

Request an appointment, or call or text us.

Sources

  1. Barrera, F., Azócar, L., Molina, H., Schalper, K. A., Ocares, M., Liberona, J., Villarroel, L., Pimentel, F., Pérez-Ayuso, R. M., Nervi, F., Groen, A. K., & Miquel, J. F. (2015). Effect of cholecystectomy on bile acid synthesis and circulating levels of fibroblast growth factor 19. Annals of Hepatology, 14(5), 710-721. https://pubmed.ncbi.nlm.nih.gov/26256900/
  2. Chang, J. Y., Jung, H.-K., Moon, C. M., Kim, S.-E., Shim, K.-N., Jung, S.-A., & Min, S. K. (2023). Development of functional gastrointestinal disorder symptoms following laparoscopic cholecystectomy: A prospective cohort study. Frontiers in Medicine, 10, 1248465. https://doi.org/10.3389/fmed.2023.1248465
  3. Farrugia, A., Attard, J. A., Hanmer, S., Bullock, S., McKay, S., Al-Azzawi, M., Ali, R., Bond-Smith, G., Colleypriest, B., Dyer, S., Masterman, B., Okocha, M., Osborne, A., Patel, R., Sallam, M., Selveraj, E., Shalaby, S., Sun, W., Todd, F., … Arasaradnam, R. P. (2021). Rates of bile acid diarrhoea after cholecystectomy: A multicentre audit. World Journal of Surgery, 45(8), 2447-2453. https://doi.org/10.1007/s00268-021-06147-8
  4. Farrugia, A., Williams, N., Khan, S., & Arasaradnam, R. P. (2024). Bile acid diarrhoea and metabolic changes after cholecystectomy: A prospective case-control study. BMC Gastroenterology, 24(1), 282. https://doi.org/10.1186/s12876-024-03368-8
  5. Hansen, M., Sonne, D. P., Mikkelsen, K. H., Gluud, L. L., Vilsbøll, T., & Knop, F. K. (2017). Bile acid sequestrants for glycemic control in patients with type 2 diabetes: A systematic review with meta-analysis of randomized controlled trials. Journal of Diabetes and Its Complications, 31(5), 918-927. https://doi.org/10.1016/j.jdiacomp.2017.01.011
  6. Janowitz, P., Kratzer, W., Zemmler, T., Tudyka, J., & Wechsler, J. G. (1994). Gallbladder sludge: spontaneous course and incidence of complications in patients without stones. Hepatology, 20(2), 291-294. https://pubmed.ncbi.nlm.nih.gov/8045489/
  7. Posserud, I., Stotzer, P.-O., Björnsson, E. S., Abrahamsson, H., & Simrén, M. (2007). Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut, 56(6), 802-808. https://doi.org/10.1136/gut.2006.108712
  8. Sung, H. J., Paik, C. N., Chung, W. C., Lee, K. M., Yang, J. M., & Choi, M. G. (2015). Small intestinal bacterial overgrowth diagnosed by glucose hydrogen breath test in post-cholecystectomy patients. Journal of Neurogastroenterology and Motility, 21(4), 545-551. https://doi.org/10.5056/jnm15020
  9. Wedlake, L., A’Hern, R., Russell, D., Thomas, K., Walters, J. R. F., & Andreyev, H. J. N. (2009). Systematic review: The prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome. Alimentary Pharmacology & Therapeutics, 30(7), 707-717. https://doi.org/10.1111/j.1365-2036.2009.04081.x
  10. Welsh, F. K., Ramsden, C. W., MacLennan, K., Sheridan, M. B., Barclay, G. R., Guillou, P. J., & Reynolds, J. V. (1998). Increased intestinal permeability and altered mucosal immunity in cholestatic jaundice. Annals of Surgery, 227(2), 205-212. https://doi.org/10.1097/00000658-199802000-00009

Dr. Gurpreet Singh Padda, MD, MBA, MHP

Schedule An Appointment

We’d be happy to answer any questions you have via email, or you can give us a call for a quick response.

Recent Blogs